Advances in the clinical management of primary hyperaldosteronism
10.3969/j.issn.1009-8291.2025.09.013
- VernacularTitle:原发性醛固酮增多症的临床诊治进展
- Author:
Huasheng LIAO
1
;
Yizhao WU
;
Cai DENG
;
Zijian AO
;
Lichao ZHANG
Author Information
1. 广州市第十二人民医院泌尿外科,广东 广州 510799
- Publication Type:Journal Article
- Keywords:
primary hyperaldosteronism;
adrenal vein sampling;
radiofrequency ablation;
arterial embolization
- From:
Journal of Modern Urology
2025;30(9):797-802
- CountryChina
- Language:Chinese
-
Abstract:
Primary hyperaldosteronism(PHA),the most common cause of secondary hypertension,can lead to cardiovascular and renal damage events.Early diagnosis and accurate typing of PHA is crucial to the choice of treatment options,and its diagnostic modalities usually include prone test screening,captopril test characterization and adrenal vein blood sampling for localization and typing diagnosis.However,with the development of imaging,molecular biology and morphology technologies,the use of nuclear medicine PET-CT,genetic testing and pathological diagnostic methods can also be used to accurately typify PHA.New technologies such as adrenal artery embolization and adrenal radiofrequency ablation are also increasingly being used in the treatment of PHA,which have the advantages of shorter and less costly surgery,fewer postoperative complications,and quicker recovery.This article provides a review of the developments in the screening,diagnosis and treatment of PHA with a view to informing clinical practice.
